Abstract:We assessed the optimal cut‐off values for glycated albumin (GA), 1,5‐anhydroglucitol (1,5‐AG), and fructosamine using receiver operating characteristic (ROC) curve and the upper or lower limit of the reference range (97.5 or 2.5 percentiles). Lowering the GA cutoff values yielded a marked enhancement in sensitivity and detected more individuals with diabetes progression. In contrast, adjusting the cutoff values for 1,5‐AG and fructosamine offered no noticeable diagnostic benefits. Background Glycated albumin (GA), 1,5‐anhydroglucitol (1,5‐AG), and fructosamine have attracted considerable interest as markers of hyperglycemia. This study aimed to evaluate the optimal cutoff values for GA, 1,5‐AG, and fructosamine and to determine their respective diagnostic efficacies in relation to hyperglycemia. Methods We enrolled 6012 individuals who had undergone fasting blood glucose (FBG) and Hemoglobin A1c (HbA1c) tests along with at least one alternative glycemic marker. Receiver operating characteristic (ROC) curves and the upper or lower limit of the reference range (97.5 or 2.5 percentiles) were used to ascertain the optimal cutoff values. Follow‐up data from healthy individuals were used to identify patients who developed diabetes mellitus (DM). Results The ROC cutoff values for GA, 1,5‐AG, and fructosamine were 13.9%, 13.3 μg/mL, and 278 μmol/L, respectively, with corresponding area under the curve (AUC) values of 0.860, 0.879, and 0.834. The upper limits of the reference intervals for GA and fructosamine were 15.1% and 279 μmol/L, respectively, and the lower limit for 1,5‐AG was 5.3 μg/mL. Among the GA cutoff values, the ROC cutoff had the highest sensitivity. Analyzing the follow‐up data showed that lowering the GA cutoff from 16.0% to 13.9% identified an additional 40 people with DM progression. Conclusions Lowering the GA cutoff values significantly increased the sensitivity of DM diagnosis and enhanced its potential as a screening marker by identifying more individuals with diabetes progression. Conversely, modifications to the cutoff values for 1,5‐AG and fructosamine did not confer any discernible diagnostic or predictive advantages.

Serum 1, 5-anhydroglucitol, glycated albumin and glycated albumin to glycated hemoglobin A 1c ratio in early identification of fulminant type 1 diabetes mellitus

Serum 1,5-Anhydroglucitol to Glycated Albumin Ratio Can Help Early Distinguish Fulminant Type 1 Diabetes Mellitus from Newly Onset Type 1A Diabetes Mellitus

HbA<sub>1c</sub> combined with glycated albumin or 1,5-anhydroglucitol improves the efficiency of diabetes screening in a Chinese population

HbA 1c combined with glycated albumin or 1,5‐anhydroglucitol improves the efficiency of diabetes screening in a Chinese population

Optimal 1,5-anhydroglucitol cut-off points for diagnosing diabetes based on prevalence of retinopathy in Chinese population

[Combined utility of hemoglobin A1c and glycated albumin in diabetic screening].

Combining Serum 1,5-Anhydroglucitol with Fasting Plasma Glucose to Detect Diabetes Mellitus in a Community-Based Population with Hypertension

Significance of glycosylated hemoglobin A1c and glycated albumin for the diagnosis of gestational diabetes mellitus

Assessment of enzymatic method for glycated albumin and its correlation research with the diagnosis of diabetes mellitus

The role of monitoring plasma 1,5-anhydroglucitol in newly diagnosed type 2 diabetic patients

1,5-Anhydroglucitol is Associated with Early-Phase Insulin Secretion in Chinese Patients with Newly Diagnosed Type 2 Diabetes Mellitus

Serum 1,5-Anhydroglucitol when Used with Fasting Plasma Glucose Improves the Efficiency of Diabetes Screening in a Chinese Population

Clinical significance of measurement of glycated albumin in impaired glucose regulation and newly diagnosed diabetes

Combined Assessment of Glycated Albumin and Fasting Plasma Glucose Improves the Detection of Diabetes in Chinese Subjects

Cutoff Values for Glycated Albumin, 1,5‐Anhydroglucitol, and Fructosamine as Alternative Markers for Hyperglycemia

Glycated albumin:an effective marker for assessing glycemic control in diabetic inpatients

Role of hemoglobin A1c at different cut-off points for diabetes diagnosis

Glycated albumin is superior to glycated hemoglobin for glycemic control assessment at an early stage of diabetes treatment: A multicenter, prospective study

Diagnostic Value of Glycated Haemoglobin (hba1c) Detection As a Screening Test for Diabetes Mellitus

Combined Use of Fasting Plasma Glucose and Glycated Hemoglobin A1c in the Screening of Diabetes and Impaired Glucose Tolerance

Snap diagnosis of fulminant type 1 diabetes by the normalized glucose/HbA1c ratio